Tung Roger D's Form 4 filing
Concert Pharmaceuticals, Inc. (CNCE) · filed Jan 7, 2022
- Accession no.
- 0001209191-22-002405
- Filed
- Jan 7, 2022
- Trade date
- Dec 14, 2021-Jan 6, 2022
- Filing delay
- 24 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $28.6K. It was filed 24 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tung Roger DCIK 0001594857 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2021 | Common Stock | GGiftDisposed | −7,000 | $0.00 | $0 | 801,578 | Direct | |
| Dec 15, 2021 | Common Stock | GGiftDisposed | −7,500 | $0.00 | $0 | 794,078 | Direct | |
| Jan 6, 2022 | Common Stock | SSaleDisposed | −9,240 | $3.09F3 | −$28,551.6 | 784,838 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $3.00 to $3.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.
Referenced by the price of 1 transaction in Table I.